See more : ChemoMetec A/S (CHEMM.CO) Income Statement Analysis – Financial Results
Complete financial analysis of DVx Inc. (3079.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DVx Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Biomotion Sciences Ordinary Shares (SLXN) Income Statement Analysis – Financial Results
- Hindustan Aeronautics Limited (HAL.NS) Income Statement Analysis – Financial Results
- Martifer SGPS, S.A. (MAR.LS) Income Statement Analysis – Financial Results
- Lighting and Equipment Public Company Limited (L&E.BK) Income Statement Analysis – Financial Results
- Xeris Biopharma Holdings, Inc. (0A8E.L) Income Statement Analysis – Financial Results
DVx Inc. (3079.T)
About DVx Inc.
DVx Inc. engages in the import/export of medical devices and related peripheral devices in Japan. The company sells arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters. It also offers ischemia-related products, including excimer laser systems; RADPAD, which reduces scatter radiation exposure to medical personnel during fluoroscopy procedures; RADNEK that reduces scatter radiation exposure to the thyroid in medical personnel during fluoroscopy procedures; RADCAP, which reduces scatter radiation exposure to the head of medical personnel during fluoroscopy procedures; and resolution/resolution SD and wonder belt products. In addition, the company engages in the research, development, manufacture, sale, repair, and leasing of medical devices and related peripheral devices; provision of internal and external medical and medical device-related general consulting and services; and medical publishing and market research activities. DVx Inc. was founded in 1986 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 45.85B | 47.48B | 45.50B | 41.01B | 44.65B | 40.38B | 38.28B | 35.27B | 31.37B | 28.65B | 26.42B | 22.87B | 20.49B | 18.00B | 15.79B | 13.08B | 11.74B |
| Cost of Revenue | 41.09B | 42.03B | 40.16B | 36.05B | 39.12B | 34.85B | 32.85B | 29.95B | 26.37B | 23.75B | 21.76B | 18.78B | 16.76B | 14.58B | 12.61B | 10.37B | 9.18B |
| Gross Profit | 4.76B | 5.46B | 5.34B | 4.96B | 5.53B | 5.53B | 5.43B | 5.31B | 5.00B | 4.89B | 4.66B | 4.09B | 3.73B | 3.43B | 3.19B | 2.72B | 2.56B |
| Gross Profit Ratio | 10.39% | 11.49% | 11.73% | 12.09% | 12.39% | 13.70% | 14.17% | 15.07% | 15.94% | 17.08% | 17.64% | 17.88% | 18.19% | 19.03% | 20.17% | 20.76% | 21.79% |
| Research & Development | 30.00M | 15.00M | 7.00M | 28.00M | 158.00M | 94.00M | 138.27M | 36.97M | 34.60M | 33.00M | 21.00M | 15.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 223.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.93B | 3.99B | 3.93B | 3.91B | 4.25B | 4.16B | 3.83B | 3.65B | 3.37B | 3.38B | 3.28B | 2.89B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 148.59M | 6.43M | 1.08M | 1.74M | 9.72M | 79.42M | 954.00K | 1.93M | 4.48M | 11.13M | 8.55M | 5.32M | 628.00K | 1.59M | 2.05M | 4.77M | 5.09M |
| Operating Expenses | 4.11B | 4.12B | 4.08B | 4.11B | 4.42B | 4.29B | 4.10B | 3.79B | 3.51B | 3.46B | 3.36B | 2.96B | 2.83B | 2.65B | 2.52B | 2.25B | 2.10B |
| Cost & Expenses | 45.20B | 46.14B | 44.24B | 40.16B | 43.54B | 39.14B | 36.96B | 33.74B | 29.88B | 27.22B | 25.12B | 21.75B | 19.59B | 17.22B | 15.13B | 12.62B | 11.28B |
| Interest Income | 1.06M | 1.25M | 80.00K | 142.00K | 310.00K | 481.00K | 1.47M | 5.27M | 5.20M | 378.00K | 344.00K | 239.00K | 101.00K | 377.00K | 1.72M | 3.46M | 1.73M |
| Interest Expense | 251.00K | 125.00K | 80.00K | 49.00K | 212.00K | 380.00K | 294.00K | 317.00K | 603.00K | 764.00K | 1.16M | 2.29M | 3.87M | 5.88M | 6.52M | 4.49M | 5.21M |
| Depreciation & Amortization | 432.22M | 391.27M | 366.04M | 386.08M | 282.90M | 220.35M | 174.63M | 141.49M | 126.10M | 110.50M | 85.94M | 83.18M | 87.64M | 92.18M | 68.94M | 64.61M | 58.33M |
| EBITDA | 807.98M | 1.74B | 1.62B | 1.23B | 1.38B | 1.57B | 1.40B | 1.63B | 2.05B | 1.56B | 1.40B | 1.19B | 959.41M | 709.97M | 687.54M | 570.66M | 531.90M |
| EBITDA Ratio | 1.76% | 3.67% | 3.57% | 3.02% | 3.16% | 3.84% | 3.94% | 4.58% | 5.18% | 5.46% | 5.21% | 5.21% | 4.71% | 4.24% | 4.71% | 4.26% | 4.53% |
| Operating Income | 653.15M | 1.34B | 1.25B | 847.39M | 1.12B | 1.24B | 1.32B | 1.52B | 1.49B | 1.43B | 1.30B | 1.12B | 892.84M | 779.87M | 661.28M | 463.34M | 459.41M |
| Operating Income Ratio | 1.42% | 2.82% | 2.75% | 2.07% | 2.50% | 3.06% | 3.45% | 4.32% | 4.76% | 4.99% | 4.91% | 4.92% | 4.36% | 4.33% | 4.19% | 3.54% | 3.91% |
| Total Other Income/Expenses | -277.64M | 10.02M | 6.65M | -1.93M | -18.87M | 110.86M | -94.97M | -34.52M | 426.71M | 21.08M | 10.55M | -19.99M | -25.10M | -168.24M | -49.31M | 38.21M | -39.49M |
| Income Before Tax | 375.51M | 1.35B | 1.26B | 845.47M | 1.10B | 1.35B | 1.23B | 1.49B | 1.92B | 1.45B | 1.31B | 1.10B | 867.75M | 611.64M | 611.97M | 501.55M | 419.92M |
| Income Before Tax Ratio | 0.82% | 2.84% | 2.77% | 2.06% | 2.46% | 3.34% | 3.20% | 4.23% | 6.12% | 5.07% | 4.95% | 4.83% | 4.24% | 3.40% | 3.87% | 3.83% | 3.58% |
| Income Tax Expense | 202.60M | 414.39M | 395.81M | 273.10M | 304.88M | 373.89M | 369.26M | 464.46M | 629.41M | 531.11M | 519.12M | 421.91M | 391.71M | 254.49M | 287.12M | 223.69M | 183.57M |
| Net Income | 172.91M | 936.18M | 863.02M | 572.37M | 792.03M | 974.18M | 856.13M | 1.03B | 1.29B | 919.95M | 788.55M | 682.74M | 476.04M | 357.15M | 324.85M | 277.86M | 236.35M |
| Net Income Ratio | 0.38% | 1.97% | 1.90% | 1.40% | 1.77% | 2.41% | 2.24% | 2.91% | 4.11% | 3.21% | 2.98% | 2.99% | 2.32% | 1.98% | 2.06% | 2.12% | 2.01% |
| EPS | 16.58 | 90.21 | 83.56 | 55.60 | 75.56 | 88.46 | 75.91 | 90.98 | 114.36 | 81.57 | 69.92 | 60.54 | 42.21 | 31.67 | 29.06 | 25.43 | 44.29 |
| EPS Diluted | 16.58 | 90.04 | 83.33 | 55.50 | 75.56 | 88.46 | 75.91 | 90.98 | 114.36 | 81.57 | 69.92 | 60.54 | 42.21 | 31.67 | 28.94 | 25.24 | 43.12 |
| Weighted Avg Shares Out | 10.43M | 10.38M | 10.33M | 10.29M | 10.48M | 11.01M | 11.28M | 11.28M | 11.28M | 11.28M | 11.28M | 11.28M | 11.28M | 11.28M | 11.18M | 10.93M | 5.34M |
| Weighted Avg Shares Out (Dil) | 10.43M | 10.40M | 10.36M | 10.31M | 10.48M | 11.01M | 11.28M | 11.28M | 11.28M | 11.28M | 11.28M | 11.28M | 11.28M | 11.28M | 11.22M | 11.01M | 5.48M |
Source: https://incomestatements.info
Category: Stock Reports